XML 34 R8.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Operating activities      
Net Loss $ (103,488) $ (189,304) $ (134,702)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Credit loss expense 2,134 6,106 1,704
Depreciation and amortization 25,244 25,689 26,460
Amortization of financing costs charged to interest expense 1,522 1,633 1,648
Amortization of right-of-use asset 2,165 2,187 3,055
Impairment of goodwill and intangible assets 58,843 131,595 70,518
Gain (Loss) on Disposition of Business (4,831) 0 6,550
Gain on debt extinguishment 0 (13,017) 0
Stock-based compensation expense 28,129 40,367 40,980
Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) 102 210 1,246
Other non-cash expense (income), net (6,243) 1,481 (4,170)
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]      
Accounts receivable and contracts assets, net 20,643 12,497 (7,725)
Prepaid expenses and other assets 1,803 1,360 2,492
Accounts payable 179 499 239
Other accrued expenses (724) (6,644) (7,492)
Partner Share liability (8,208) (16,350) 405
Customer Incentive liability (7,980) (7,133) (1,393)
Net cash provided by (used in) operating activities 9,290 (8,824) (185)
Investing activities      
Acquisition of property and equipment (480) (1,562) (667)
Capitalized software development costs (15,302) (17,736) (11,725)
Proceeds from Divestiture of Businesses, Net of Cash Divested 480 552 2,330
Net cash used in investing activities (15,302) (18,746) (10,062)
Financing activities      
Proceeds from issuance of debt 56,000 172,500 30,000
Principal payments of debt (62,000) (199,303) (31)
Proceeds from termination of capped calls related to convertible notes 0 115 0
Proceeds from issuance of common stock 0 48,645 55
Settlement of contingent consideration (5,000) (14,167) (50,050)
Equity issuance costs 0 (309) 0
Debt issuance costs (122) (6,037) 0
Net cash (used in) provided by financing activities (11,122) 1,444 (20,026)
Effect of exchange rates on cash, cash equivalents and restricted cash 259 (110) 118
Net decrease in cash, cash equivalents and restricted cash (16,875) (26,236) (30,155)
Cash, cash equivalents, and restricted cash — Beginning of period 65,594 91,830 121,985
Cash, cash equivalents, and restricted cash — End of period 48,719 65,594 91,830
Supplemental Cash Flow Information [Abstract]      
Cash and cash equivalents 48,719 65,594 91,830
Restricted cash 0 0 0
Total cash, cash equivalents and restricted cash — End of period 48,719 65,594 91,830
Supplemental schedule of non-cash investing and financing activities:      
Cash paid for interest 9,260 6,119 4,240
Amounts accrued for property and equipment 12 95 579
Amounts accrued for capitalized software development costs 39 174 40
Issuance of common stock, net of issuance costs - Settlement Agreement (as defined below) $ 0 $ 27,451 $ 0